Autoimmune hepatitis with centrilobular necrosis

被引:64
作者
Misdraji, J
Thiim, M
Graeme-Cook, FM
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol,James Homer Wright Pathol Labs, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA
关键词
autoimmune hepatitis; centrilobular necrosis; zone; 3; hepatitis; zonal necrosis; confluent necrosis;
D O I
10.1097/00000478-200404000-00006
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Autoimmune hepatitis (AIH) is usually a chronic portalbased hepatitis with prominent plasma cells. Although necroinflammatory activity throughout the lobule is described, centrilobular necrosis (CN) is only rarely the predominant pattern of injury. Recognition of the possibility of AIH in zone 3 hepatitis will lead to prompt steroid therapy and may avert cirrhosis. We report the clinicopathologic features of 6 cases of AIH with CN. The 3 females and 3 males averaged 48 years of age (range 32-66 years). Four patients had a history of autoimmune disorders. All had elevated transaminases and negative serology for viral hepatitis B and C. One had a history of ethanol use. One patient was taking interferon-beta and 1 patient was taking atorvastatin, but none of the patients was taking medication with a temporal relationship to suggest a drug hypersensitivity hepatitis. All patients had positive antinuclear antibody, anti-smooth muscle antibody, or both, although 1 patient was negative for autoantibodies at initial laboratory testing. Four biopsies showed confluent zone 3 necrosis, whereas two biopsies showed spotty CN. Portal inflammation was relatively mild in all cases. Plasma cells were few to numerous in both zone 3 and portal tracts in four biopsies; they were absent in 2 cases. All patients responded to steroid therapy. Two patients relapsed, and rebiopsy in 1 of them showed CN, bridging necrosis, and an increase in the degree of portal-based hepatitis. Another patient was not treated initially; a second biopsy 35 months after presenting revealed periportal hepatitis as well as CN. The histologic spectrum of AM should be expanded to include zone 3 hepatitis. As with classic AIH, most patients with CN demonstrate serologic and clinical evidence of autoimmunity. Subsequent biopsies in patients with a centrilobular pattern may show evolution to portal-based hepatitis characteristic of AIH but may also show persistence of the zone 3 hepatitis. Unlike other causes of zone 3 hepatitis, AIH is steroid responsive; therefore, timely diagnosis is important.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 24 条
[1]
International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].
Alvarez, E ;
Berg, PA ;
Bianchi, FB ;
Bianchi, L ;
Burroughs, AK ;
Cancado, EL ;
Chapman, RW ;
Cooksley, WGE ;
Czaja, AJ ;
Desmet, VJ ;
Donaldson, RT ;
Eddleston, ALWF ;
Fainboim, L ;
Heathcote, J ;
Homberg, JC ;
Hoofnagle, JH ;
Kakumu, S ;
Krawitt, EL ;
Mackay, IR ;
MacSween, RNM ;
Maddrey, WC ;
Manns, MP ;
McFarlane, IG ;
zum Büschenfelde, KHM ;
Mieli-Vergani, G ;
Nakanuma, Y ;
Nishioka, M ;
Penner, E ;
Porta, G ;
Portmann, BC ;
Reed, WD ;
Rodes, J ;
Schalm, SW ;
Scheuer, PJ ;
Schrumpf, E ;
Seki, T ;
Toda, G ;
Tsuji, T ;
Tygstrup, N ;
Vergani, D ;
Zeniya, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938
[2]
RECENT-ONSET AUTOIMMUNE HEPATITIS - BIOPSY FINDINGS AND CLINICAL CORRELATIONS [J].
BURGART, LJ ;
BATTS, KP ;
LUDWIG, J ;
NIKIAS, GA ;
CZAJA, AJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (06) :699-708
[3]
Autoimmune hepatitis with incidental histologic features of bile duct injury [J].
Czaja, AJ ;
Carpenter, HA .
HEPATOLOGY, 2001, 34 (04) :659-665
[4]
Czaja Albert J., 2000, Hepatology, V31, P1194, DOI 10.1053/he.2000.5980
[5]
Duchini A, 2002, AM J GASTROENTEROL, V97, P767
[6]
HISTOLOGICAL GRADING AND STAGING OF CHRONIC HEPATITIS [J].
ISHAK, K ;
BAPTISTA, A ;
BIANCHI, L ;
CALLEA, F ;
DEGROOTE, J ;
GUDAT, F ;
DENK, H ;
DESMET, V ;
KORB, G ;
MACSWEEN, RNM ;
PHILLIPS, MJ ;
PORTMANN, BG ;
POULSEN, H ;
SCHEUER, PJ ;
SCHMID, M ;
THALER, H .
JOURNAL OF HEPATOLOGY, 1995, 22 (06) :696-699
[7]
Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus [J].
Jiménez-Alonso, J ;
Osorio, JM ;
Gutiérrez-Cabello, F ;
de la Osa, AL ;
León, L ;
García, JDM .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (15) :1811-1812
[8]
MEETING REPORT - INTERNATIONAL-AUTOIMMUNE-HEPATITIS-GROUP [J].
JOHNSON, PJ ;
MCFARLANE, IG ;
ALVAREZ, F ;
BIANCHI, FB ;
BIANCHI, L ;
BURROUGHS, A ;
CHAPMAN, RW ;
CZAJA, AJ ;
DESMET, V ;
EDDLESTON, ALWF ;
GERBER, MA ;
HOFFNAGLE, JH ;
KAKUMU, S ;
MACSWEEN, RNM ;
MADDREY, WC ;
MANNS, MP ;
ZUMBUSCHENFELDE, KHM ;
MIELIVERGANI, G ;
PORTMANN, BC ;
REED, WD ;
SCHALM, SW ;
SCHEUER, PJ ;
TODA, G ;
TSUJI, T ;
TYGSTRUP, N ;
VERGANI, D ;
ZENIYA, M .
HEPATOLOGY, 1993, 18 (04) :998-1005
[9]
De-novo autoimmune hepatitis after liver transplantation [J].
Kerkar, N ;
Hadzic, N ;
Davies, ET ;
Portmann, B ;
Donaldson, PT ;
Rela, M ;
Heaton, ND ;
Vergani, D ;
Mieli-Vergani, G .
LANCET, 1998, 351 (9100) :409-413
[10]
Autoimmune hepatitis: Clinical challenges [J].
Manns, MP ;
Strassburg, CP .
GASTROENTEROLOGY, 2001, 120 (06) :1502-1517